| P50 | author | Choung-Soo Kim | Q56635696 |
| | Hanjong Ahn | Q86850554 |
| P2093 | author name string | Sejun Park | |
| | Yunlim Kim | |
| | Sahyun Pak | |
| | Chan-Hee Park | |
| | Jung-Hyuck Park | |
| | Kyoung-June Lee | |
| P2860 | cites work | The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway | Q24322825 |
| | Sam68 Allows Selective Targeting of Human Cancer Stem Cells. | Q50925360 |
| | The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer. | Q52684450 |
| | Cancer stem cells | Q80312237 |
| | Wnt/β-catenin signaling and disease | Q26823272 |
| | The Wnt signaling pathway in development and disease | Q27861019 |
| | Linking beta-catenin to androgen-signaling pathway | Q28215632 |
| | The mutational landscape of lethal castration-resistant prostate cancer | Q29614634 |
| | Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress | Q29615495 |
| | WNT signalling pathways as therapeutic targets in cancer | Q29615666 |
| | Increased survival with enzalutamide in prostate cancer after chemotherapy | Q29617511 |
| | Abiraterone and increased survival in metastatic prostate cancer | Q29617512 |
| | Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription | Q33292178 |
| | The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens | Q33316388 |
| | Inhibition of androgen receptor and β-catenin activity in prostate cancer | Q34982553 |
| | Wnt/β-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells | Q35557572 |
| | Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma | Q35890853 |
| | Stem cells in prostate cancer initiation and progression | Q35916167 |
| | ER stress and the unfolded protein response | Q35986601 |
| | Expression and colocalization of β-catenin and lymphoid enhancing factor-1 in prostate cancer progression | Q36796016 |
| | Tumor hypoxia blocks Wnt processing and secretion through the induction of endoplasmic reticulum stress | Q36994741 |
| | CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment | Q37190326 |
| | Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma | Q37228472 |
| | The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies | Q37285838 |
| | Carfilzomib Triggers Cell Death in Chronic Lymphocytic Leukemia by Inducing Proapoptotic and Endoplasmic Reticulum Stress Responses | Q37427124 |
| | Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 |
| | Endoplasmic reticulum stress and the unfolded protein response: targeting the Achilles heel of multiple myeloma. | Q38111315 |
| | Wnt signaling in castration-resistant prostate cancer: implications for therapy | Q38241850 |
| | Controlling the unfolded protein response-mediated life and death decisions in cancer. | Q38392861 |
| | Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis. | Q38482230 |
| | Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2015. | Q38615620 |
| | Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. | Q38807957 |
| | Revisiting the role of Wnt/β-catenin signaling in prostate cancer | Q39131794 |
| | Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics | Q39400127 |
| | Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer | Q39910338 |
| | Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. | Q40291997 |
| | Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells | Q40411544 |
| | Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer | Q40571932 |
| | Activation of β-catenin signaling in androgen receptor-negative prostate cancer cells | Q40834731 |
| | Apoptosis-induced cleavage of beta-catenin by caspase-3 results in proteolytic fragments with reduced transactivation potential | Q40889527 |
| | WNT signalling in prostate cancer. | Q47818549 |
| | Commentary on "AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer." Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC, Chen Y, Mohammad TA, Chen Y, Fedor HL, Lotan TL, Zheng Q, De Marzo AM, Isaacs JT, Isaacs WB, Nadal | Q47860314 |
| | Role of Wnt Signalling in Advanced Prostate Cancer | Q48289501 |
| P2507 | corrigendum / erratum | Correction to: The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway | Q91009798 |
| P433 | issue | 1 | |
| P921 | main subject | prostate cancer | Q181257 |
| | endoplasmic reticulum | Q79927 |
| P304 | page(s) | 342 | |
| P577 | publication date | 2019-08-06 | |
| P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
| P1476 | title | The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway | |
| P478 | volume | 38 | |